OTC · Medical - Instruments & Supplies

Nanosonics Limited (NNCSF) Stock

$2.07 -5.48% OTC: NNCSF Healthcare

Nanosonics Limited, in conjunction with its subsidiaries, functions as an infection prevention enterprise, serving both Australian and international markets. The company's core activities involve the production and supply of the trophon ultrasound probe disinfector, alongside its complementary consumables and accessories.

Valuation

MetricValue
Price$2.07
Market Cap$618.75M
P/E Ratio46.97
P/B Ratio4.40
P/S Ratio4.58
EPS (TTM)$0.04
52-Week High$3.06
52-Week Low$2.01
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE9.57%
ROA7.36%
ROCE7.65%
Gross Margin77.17%
Operating Margin8.95%
Net Margin9.91%
Debt/Equity0.04
Current Ratio6.38

Annual Financials (USD)

Metric20212022202320242025
Revenue$103.0M$120.0M$168.0M$170.0M$199.0M
Operating Profit$11.0M$2.0M$20.0M$9.0M$9.0M
Net Profit$9.0M$4.0M$20.0M$13.0M$21.0M
EPS$0.03$0.01$0.06$0.04$0.07
Op Margin10.4%1.5%11.7%5.4%4.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$165.0M$193.0M$226.0M$237.0M$272.0M
Total Liabilities$29.0M$55.0M$62.0M$55.0M$63.0M
Cash$96.0M$95.0M$112.0M$130.0M$161.0M
Borrowings$2.0M$12.0M$11.0M$9.0M$8.0M

Latest News

ASX Growth Stocks With High Insider Ownership Simply Wall St. · Jun 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$7.0M$7.0M$23.0M$23.0M$44.0M
Investing Cash Flow$-3.0M$-14.0M$-7.0M$-5.0M$-17.0M
Financing Cash Flow$-1.0M$0$0$-3.0M$-4.0M
Net Cash Flow$4.0M$-2.0M$18.0M$17.0M$32.0M
Free Cash Flow$6.0M$0$20.0M$20.0M$35.0M

Valuation & Return Ratios

MetricValue
PEG Ratio1.87
EV / EBITDA27.55
FCF Yield2.56%
Quick Ratio5.75
Interest Coverage12.55
Return 1Y-14.04%
Return 3Y-29.13%
Return 5Y—

Ownership

Insiders Held15.88%
Institutions Held64.60%
Institutions Float Held76.80%
Institutional HolderSharesReport Date
Gofen & Glossberg LLC90,0512022-12-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARRJFArjo AB (publ) $2.74 +0.00% 19.10 $746.29M 3.65%
HGYMFHogy Medical Co.,Ltd. $43.47 +24.24% 483.66 $937.20M 1.54%
LFTSFLifeTech Scientific Corporation $0.23 +0.00% 38.30 $1.03B 0.00%
PHCIPanamera Holdings Corporation $2.50 +0.00% -1.20 $184.72M 0.00%
SAFLFSafilo Group S.p.A. $1.86 +0.00% 15.83 $731.41M 0.00%

About Nanosonics Limited

Nanosonics Limited, in conjunction with its subsidiaries, functions as an infection prevention enterprise, serving both Australian and international markets. The company's core activities involve the production and supply of the trophon ultrasound probe disinfector, alongside its complementary consumables and accessories. Furthermore, Nanosonics is committed to the research, development, and market introduction of innovative infection control and decontamination products and related technologies. Its product portfolio features the trophon2, a sophisticated device for high-level disinfection of ultrasound probes; trophon EPR, a specialized low-temperature, high-level disinfection solution specifically for intra-cavity ultrasound transducers; and Nanosonics AuditPro, a comprehensive system for managing compliance with infection control workflows. Established in 2000, Nanosonics Limited maintains its corporate headquarters in Macquarie Park, Australia.

Nanosonics Limited is headquartered in AU.

Nanosonics Limited (NNCSF) stock trades at $2.07 with a market capitalization of $618.75M. The stock is valued at a price-to-earnings (P/E) ratio of 46.97, price-to-book of 4.40, price-to-sales of 4.58. Over the past 52 weeks the stock has ranged between $2.01 and $3.06, and currently trades 32.4% below its 52-week high.

On profitability, Nanosonics Limited generates a return on equity (ROE) of 9.57%, return on capital employed of 7.65%, an operating margin of 8.95%, a net profit margin of 9.91%.

Official website: www.nanosonics.com.au

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides